share_log

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $22 Price Target

Benzinga ·  Mar 18 11:05

D. Boral Capital analyst Jason Kolbert maintains AVITA Medical (NASDAQ:RCEL) with a Buy and maintains $22 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 320

Recommended

Write a comment